Serum il-5 levels predict hbsag seroclearance in patients treated with nucleos(t)ide analogues combined with pegylated interferon

HIGHLIGHTS

• who: Peipei Wang and collaborators from the Capital Medical University, China have published the article: Serum IL-5 levels predict HBsAg seroclearance in patients treated with Nucleos(t)ide analogues combined with pegylated interferon, in the Journal: (JOURNAL)
• how: Flow cytometry data were analyzed using FlowJo (version 10.4.0). Data were analyzed using SPSS (version 21.0 for Windows Chicago IL USA).

SUMMARY

Interleukin (IL)-2 is associated with the evaluation of functions in T_cells, especially in the HBV- specific T_cells during the natural course of HBV infection, as well . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.